1. MEDICAL EDUCATION GROUP LLC
Continuing
Medical
Education

2. Market Shaping Language
COPD is a complex group of disorders including
emphysema and chronic bronchitis
COPD is characterized by airflow
limitation associated with
abnormal inflammatory response
of lungs to noxious
particles/gases
While inflammation is the
common basis, asthma and
COPD differ both pathologically
and physiologically.
COPD must be treated with
advanced and targeted agents
that modulate inflammation in all
inflammatory cells

3. Innovative Product Trial Support On-line
Clinical Research With Atopic Children

6. Selection & Treatment Of
Patients with COPD:
ST P COPD
A Branded
Educational Initiative

7. Classification of COPD Severity
STAGE CHARACTERISTIC
Level 0: Normal spirometry
At Risk With chronic symptoms (cough, sputum)
Level I: FEV 1/FVC <70%; FEV 1= 80% predicted
Mild With our without chronic symptoms (cough, sputum)
Level II: FEV 1/FVC <70%; 50% ≤ FEV 1 < 80% predicted
Moderate With our without chronic symptoms (cough, sputum, dyspnea)
Level III: FEV 1/FVC <70%; 30% ≤ FEV 1 < 50% predicted
Severe With or without chronic symptoms (cough, sputum, dyspnea)
Level IV: FEV1/FVC <70%; FEV1 < 30% predicted, or
Very Severe FEV1 < 50% predicted plus chronic respiratory failure
Global Initiative for Chronic Obstructive Lung Disease. Workshop Report: Global Strategy for the Diagnosis, Management, and
Prevention of COPD; update 2004.

8. ST P COPD Rollout
Key Congresses
Key Congresses
Poster PavilionTM
Poster PavilionTM Regional Seminars
Regional Seminars Dinner Meetings
Dinner Meetings
Teleconferences
Teleconferences CaseMatsTM
CaseMatsTM E-roundsTM
E-roundsTM
Journal Plus ®
Journal Plus ® Monographs
Monographs Independent Study
Independent Study
Newsletters
Newsletters ST P COPD Website
ST P COPD Website
Provide a variety of live, interactive, and print
activities to satisfy all learning preferences

9. Launch ST P COPD Programs
At Key Meetings
Annual Meetings Dates & Sites
Meeting 2005 2006
May 20-25 May 19-24
ATS
San Diego, CA San Diego, CA
December 3-6 December
AARC
San Antonio, TX Las Vegas, NV
Jan. 31 – Feb. 3 Jan. 30 – Feb. 2
ALA
San Jose, CA San Jose, CA

10. Congress Activity Philosophy
Own Key Congresses
Pre-Meeting Special
Poster Enduring
Activities Symposium & PavilionTM Materials

11. Why MEG?

12. Medical Education Group LLC
A Fully Accredited Medical Education Company
ACCME PNA ACPE PACE COPE CDR
Medicine Nursing Pharmacy Laboratory Optometry Dietitians

13. Accreditation Details
§ Medical Education Group LLC
§ Accredited ACCME provider since 1998
§ Awarded “Exemplary Status” in Element 3.1
Organizational Structure, Resources, and Firewall
Provisions
§ In 2 survey cycles, zero noncompliance findings
Only 5.8% (13) accredited companies and institutions received exemplary status
in 2003. MEG was 1 of only 2 for-profit companies to receive the rating.

14. Core Competencies
Define the fundamental • Overall Strategy
Strategic precepts: • Key Messages
Planning • Target Audiences
• Create a cascade of • Reposition the competition
Content information • Educate physicians on
Development • Build anticipation Xolair’s impact on Allergic
Asthma
• Primary Publications • Newsletter Series • Case Studies
Information • Secondary Publications • Journal Plus • Audio CD-Rom
Dissemination • Round Tables Program • Extranet
• Poster Pavilion
• LASER Software • BioConnect
Activity • PubLog™ • Meeting Logistics
Planning & • KOLA-db Management
Quality Control